Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine...
Transcript of Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine...
![Page 1: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/1.jpg)
Star Articles in Review
Christina M. Surawicz, MD MACGProfessor of Medicine
Division of GastroenterologyDepartment of Medicine
University of Washington
CDDW/CASL MeetingToronto, February 10, 2014
![Page 2: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/2.jpg)
Disclosure of Financial Relationships
Christina M. Surawicz, MD
Has no relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
![Page 3: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/3.jpg)
Duodenal infusion of donor feces for recurrent Clostridium difficile. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal ED, de Vos WM, Visser CE, Kuijper Ejk Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ.
N Engl J Med 2013, Jan 31; 368(5):407-15
![Page 4: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/4.jpg)
Treating Infectious Diarrhea with Human Stool
1700 years ago in China(Dong-Jin Dynasty)
Human feces given to treat food poisoning and severe diarrhea
(Zhang, Am J Gastroenterol 2012; 107:1755)
![Page 5: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/5.jpg)
Recurrent C. difficile infection (RCDI) – Background• Result of disturbed microbiome
• Less diversity• Fecal microbiota transplant (FMT)
“stool transplant”- 90% effective in small series + meta-
analysis- Better than other therapies
Pulsed vancomycinAdjunct probiotics
- No prior RCT
![Page 6: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/6.jpg)
RCDI – Evidence of the Altered Microbiome
Evaluated microbiome in 7 pts with CDI and 3 controls
Bacteroidetes and Firmicutes = majority3 developed RCDI
Microbiota was less diverseMore other bacteria
Chang JY, et al, J Infect Dis. 2008;197:435-8.
![Page 7: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/7.jpg)
Colon Microbiota
Chang JY, et al, J Infect Dis. 2008;197:435-8.
![Page 8: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/8.jpg)
Patient Population• Adults with life expectancy > 3 months• Recurrent CDI -
One or more episodesFailed standard therapy
• Diarrhea> 3 loose or watery / 24 hour x 2 days
OR> 8 in 48 hours
PLUSC. difficile toxin by PCR
![Page 9: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/9.jpg)
Patient Population
Elderly (66 – 73 mean age)Men and womenMedian recurrences 2 – 3
Most had 4 episodesHospital acquired 46 (77%)Normal labs
WBC, albumin, creatinine
![Page 10: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/10.jpg)
Exclusions
Immune compromise – risk
Pregnancy
Intercurrent antibiotics – recurrence
ICU or on pressors - too sick – refractory not recurrence
![Page 11: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/11.jpg)
Donors (15) – Extensive Screening
Repeated every 4 monthsStool: Parasites, bacteria
Blood: HIV, HTLV 1 + 2,Hepatitis A, B, C, CMVEBV, syphilis, strongyloides,Entamoeba histolytica
![Page 12: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/12.jpg)
3 Groups
Regimen Number of patients
Vancomycin 2 gm/day for 14 days 13
Vancomycin 2 gm/day for 4 days with gut lavage but no donor feces infusion
13
Vancomycin 2 gm/day for 4 days with gut lavage and donor feces via nasoduodenal tube
16
![Page 13: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/13.jpg)
Method
• Fresh stool – passed within 6 hours
• Infused via nasoduodenal tube after gut lavage
![Page 14: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/14.jpg)
Outcome 1 - Recurrence10 week follow up
If recurred, 2nd infusion, different donor10 week follow up extended
Recurrence definedDiarrhea + positive C. difficile toxinNo other cause of diarrheaStools tested
Days 14, 21, 35, 70, and if diarrhea
![Page 15: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/15.jpg)
Outcome 2 - Microbiota Analysis of Stool
16 S ribosomal RNA
Diversity scale
![Page 16: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/16.jpg)
Enrollment and Outcomes
van Nood E et al. N Engl J Med 2013;368:407-415.
![Page 17: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/17.jpg)
Results• 43 patients randomized
2 patients dropped: One stopped meds at homeOne needed steroids for unrelated problem
![Page 18: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/18.jpg)
Results Vancomycin Resolution of RCDI
Regimen Response Notes
Vancomycin alone 4/13 (31%)Vancomycin and gut lavage
3/13 (23%)
Vancomycin and gut lavage and donor stool
13/16 (81%) 2/3 responded to second infusion (94%)
![Page 19: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/19.jpg)
Results
• Trial terminated early
Planned 40/each group
![Page 20: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/20.jpg)
Time to recurrence23 – 25 days
Off protocol treatment – 1 or 2 infusions15/18 83% response
![Page 21: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/21.jpg)
Adverse Events
Immediate 3 hours – resolvedDiarrhea 94%Cramps 31Belching 19
Follow upConstipation 19%
![Page 22: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/22.jpg)
Stool Microbiota – 9 Patients• Pre FMT
- Low diversity• Post FMT
- diversity - Similar to donor
• Bacterioidetes• Clostridium clusters IV, XIVa• Proteobacteria
![Page 23: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/23.jpg)
Microbiota Diversity in Patients before and after Infusion of Donor Feces, as Compared with Diversity in Healthy Donors.
van Nood E et al. N Engl J Med 2013;368:407-415.
![Page 24: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/24.jpg)
Critique 1 – Study Stopped Early
- But did wait until evaluation of the33% had reached their primary outcome
![Page 25: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/25.jpg)
Critique 2 - Unblinded
But data points collected at regular intervals in all 3 groups
Also diarrhea and C. difficile testing are objective outcomes
![Page 26: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/26.jpg)
Conclusion
FMT effective for RCDI
Nasoduodenal routeSafe Effective
![Page 27: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/27.jpg)
Unanswered Questions for Future of FMT
• Protocol• Screening of donor and recipient• Route• Amount of stool • Safety – need database
Short term and long term
![Page 28: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/28.jpg)
Long Term Follow Up of Colonoscopic FMT for RCDI
Lawrence Brandt – Bronx, NYColleen Kelly – Providence, RIMark Mellow – Oklahoma City, OKNeil Stollman – Oakland, CAChristina Surawicz – Seattle, WA
(Brandt et al, Am J Gastro, March 27, 2012)
![Page 29: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/29.jpg)
Results77 patients - 56 women
Duration - 11 months averageAge 22 - 88 (65 mean)
Resolution – within 6 days commonly91% immediate cure, 98% secondary cureOf 7 failures
2 retransplanted4 retreated
53% would have it as a 1st treatment if it recurred
![Page 30: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/30.jpg)
Long Term Safety
• 4 had a new medical conditionPeripheral neuropathySjögren syndromeITPRheumatoid arthritis
• No infections or deaths related1 sepsis – 6 months later in Crohn’s pt.1 pneumonia
![Page 31: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/31.jpg)
Safety of FMT in RCDIReports
Norovirus2 casesDonor Asymptomatic
(Gluck et al, Am J Gastroenterol 2013; 108:1367)
Flare of IBD1 case
(deLeon et al, Clin Gastro Hep 2013; 11:1036-8)
![Page 32: Star Articles in Review - cag-acg.org · Division of Gastroenterology Department of Medicine University of Washington CDDW/CASL Meeting Toronto, February 10, 2014. Disclosure of Financial](https://reader031.fdocuments.in/reader031/viewer/2022012000/6079e791441b0835a3338638/html5/thumbnails/32.jpg)
ConclusionFMT effective for RCDI – first RCT
Colonoscopic RCT – in progress (Colleen Kelly)
Needs more studyNeed long-term follow up – Data baseSafetyEfficacy